Long-term survival after anti-PD-1 discontinuation in advanced cutaneous squamous cell carcinoma (cSCC): a proof of concept of benefit of concomitant cemiplimab and radiotherapy.

Autor: Bailly-Caillé, Barbara1 (AUTHOR), Levard, Romain1 (AUTHOR) romain.levard@unicaen.fr, Kottler, Diane1 (AUTHOR), Dompmartin, Anne1 (AUTHOR), L'Orphelin, Jean-Matthieu1,2 (AUTHOR) lorphelin-jm@chu-caen.fr
Zdroj: Cancer Immunology, Immunotherapy. Jul2024, Vol. 73 Issue 7, p1-5. 5p.
Databáze: Academic Search Ultimate
Externí odkaz: